BRIEF-BULLISH SHARES INDICATED TO OPEN BETWEEN $55-$60 IN NYSE DEBUT VERSUS $37 IPO PRICE-February 2024-www.financetom.com

BRIEF-BULLISH SHARES INDICATED TO OPEN BETWEEN $55-$60 IN NYSE DEBUT VERSUS $37 IPO PRICE

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-BULLISH SHARES INDICATED TO OPEN BETWEEN $55-$60 IN NYSE DEBUT VERSUS $37 IPO PRICE

Aug 13, 2025 11:16 AM

Aug 13 (Reuters) - Bullish:

* BULLISH SHARES INDICATED TO OPEN BETWEEN $55-$60 IN NYSE

DEBUT

VERSUS $37 IPO PRICE

* BULLISH SHARES INDICATED TO OPEN BETWEEN $60-$65 IN NYSE

DEBUT

VERSUS $37 IPO PRICE

* BULLISH SHARES INDICATED TO OPEN BETWEEN $65-$70 IN NYSE

DEBUT

VERSUS $37 IPO PRICE

* BULLISH SHARES INDICATED TO OPEN BETWEEN $70-$75 IN NYSE

DEBUT

VERSUS $37 IPO PRICE

* BULLISH SHARES INDICATED TO OPEN BETWEEN $75-$80 IN NYSE

DEBUT

VERSUS $37 IPO PRICE

* BULLISH SHARES INDICATED TO OPEN BETWEEN $80-$85 IN NYSE

DEBUT

VERSUS $37 IPO PRICE

* BULLISH SHARES INDICATED TO OPEN BETWEEN $85-$88 IN NYSE

DEBUT

VERSUS $37 IPO PRICE

* BULLISH SHARES INDICATED TO OPEN BETWEEN $89-$90 IN NYSE

DEBUT

VERSUS $37 IPO PRICE

Source text:

Further company coverage:

Previous page： Day One Biopharmaceuticals Shares Rise; FDA Issues Accelerated Approval for Pediatric Low-Grade Glioma Treatment Next page： Amazon.com Launches New Grocery Delivery Subscription Service in US

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Day One Biopharmaceuticals Shares Rise; FDA Issues Accelerated Approval for Pediatric Low-Grade Glioma Treatment

Apr 23, 2024

03:54 PM EDT, 04/23/2024 (MT Newswires) -- Day One Biopharmaceuticals ( DAWN ) shares rose 10% in recent Tuesday trading after the company's Ojemda received accelerated approval from the US Food and Drug Administration for the treatment of patients six months and older with relapsed or refractory pediatric low-grade glioma harboring a BRAF fusion or rearrangement, or BRAF V600 mutation....

Amazon.com Launches New Grocery Delivery Subscription Service in US

Apr 23, 2024

03:50 PM EDT, 04/23/2024 (MT Newswires) -- Amazon.com ( AMZN ) on Tuesday launched a new grocery delivery subscription service in the US that Wedbush Securities said is likely to help the e-commerce giant capture market share, especially in perishable categories. Amazon ( AMZN ) said Prime members in more than 3,500 cities and towns can avail the service at...

WeWork founder Neumann wants bankruptcy court's help in bid to repurchase company

Apr 23, 2024

April 23 (Reuters) - WeWork ( WEWOQ ) founder Adam Neumann has asked a U.S. bankruptcy judge to help his bid to re-acquire the coworking business, saying Monday that WeWork's ( WEWOQ ) management should engage in talks or be forced to cede control of the company's restructuring. Neumann's new real estate company, Flow Global, has sought to buy WeWork...

Zillow Group 'Plenty Healthy' Despite Current Stock Reaction to Market, Regulatory Concerns, RBC Says

Apr 23, 2024

03:54 PM EDT, 04/23/2024 (MT Newswires) -- Zillow Group ( ZG ) shares are reacting to concerns about future rates, regulations and competition, but the business is plenty healthy, RBC Capital Markets said in a note Tuesday. RBC's premier agent checks showed positive trends with stable to slightly increasing spending, solid new product activity, and minimal concerns about regulations or...